CSS
MIRM icon

Cubist Systematic Strategies’s Mirum Pharmaceuticals MIRM Stock Holding History

Cubist Systematic Strategies’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$10.6M Sell
144,184
-766
-0.5% -$48.7K 0.05% 534
2025
Q2 		$7.38M Sell
144,950
-151,937
-51% -$6.76M 0.03% 785
2025
Q1 		$13.4M Buy
296,887
+212,918
+254% +$10M 0.08% 357
2024
Q4 		$3.47M Sell
83,969
-14,797
-15% -$617K 0.02% 1042
2024
Q3 		$3.85M Buy
+98,766
New +$3.94M 0.02% 998
2024
Q2 		– Sell
-7,199
Closed -$181K – 3622
2024
Q1 		$181K Sell
7,199
-47,150
-87% -$1.3M ﹤0.01% 3115
2023
Q4 		$1.6M Sell
54,349
-43,765
-45% -$1.32M 0.01% 1687
2023
Q3 		$3.1M Buy
98,114
+94,104
+2,347% +$2.58M 0.02% 1061
2023
Q2 		$104K Buy
4,010
+1,976
+97% +$52.6K ﹤0.01% 2985
2023
Q1 		$48.9K Buy
+2,034
New +$46.4K ﹤0.01% 3564
2022
Q3 		– Sell
-42,349
Closed -$824K – 4607
2022
Q2 		$824K Buy
42,349
+26,566
+168% +$627K 0.01% 2631
2022
Q1 		$348K Buy
15,783
+13,134
+496% +$268K ﹤0.01% 2755
2021
Q4 		$42K Sell
2,649
-2,591
-49% -$40.3K ﹤0.01% 3327
2021
Q3 		$104K Buy
5,240
+3,622
+224% +$58.9K ﹤0.01% 2735
2021
Q2 		$28K Sell
1,618
-6,641
-80% -$119K ﹤0.01% 2833
2021
Q1 		$164K Sell
8,259
-1,434
-15% -$27.5K ﹤0.01% 2533
2020
Q4 		$169K Buy
+9,693
New +$191K ﹤0.01% 2302
2020
Q3 		– Sell
-100
Closed -$2K – 2571
2020
Q2 		$2K Buy
+100
New +$1.67K ﹤0.01% 2358

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Cubist Systematic Strategies's MIRM Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Mirum Pharmaceuticals (MIRM) stake by 0.53% in Q3 2025, selling an estimated $48.7K and leaving 144,184 shares worth $10.6M. The position accounts for 0.05% of the portfolio, ranked #534.

Cubist Systematic Strategies first reported a position in MIRM in Q2 2020 and has held it in 18 quarters since. The position peaked at $13.4M in Q1 2025. 272 funds tracked by Wall St. Rank hold MIRM as of Q3 2025.

  • Cubist Systematic Strategies held 144,184 shares of Mirum Pharmaceuticals worth $10.6M as of Q3 2025.
  • Cubist Systematic Strategies sold 766 Mirum Pharmaceuticals shares in Q3 2025, an estimated $48.7K.
  • Mirum Pharmaceuticals made up 0.05% of Cubist Systematic Strategies's portfolio in Q3 2025, its #534 holding.
  • Cubist Systematic Strategies first reported a position in Mirum Pharmaceuticals in Q2 2020 and has held it in 18 quarters since.
  • Cubist Systematic Strategies's Mirum Pharmaceuticals position peaked at $13.4M in Q1 2025.
  • 272 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.